跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEQVIO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEQVIO
Authorized
STANDARD
LEQVIO
novartis pharmaceuticals canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b1a5282a0e98b61d
Company
novartis pharmaceuticals canada inc
Type
Standard
Approval Details
Approval Id
b1a5282a0e98b61d
Drug Approval Canada Name
LEQVIO
Product Name
LEQVIO
Status
Marketed
Status Date
2022-09-26
Original Market Date
2022-09-26
Din
02518376
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription
Atc Original
C10AX16 INCLISIRAN
Atc Name
c 10 ax 16
Aig Number
0163074001
Company Name
novartis pharmaceuticals canada inc
Company Address
100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1
Active Ingredients
INCLISIRAN (INCLISIRAN)
284 MG / 1.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b1a5282a0e98b61d
Type
Standard
Back to Health Canada Approvals